sivelestat [Ligand Id: 6441] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL76688 (Sivelestat, ONO-5046, LY-544349, LY544349)
  • cathepsin G/Cathepsin G in Human [ChEMBL: CHEMBL4071] [GtoPdb: 2348] [UniProtKB: P08311]
  • This target only has 0 pki data point
  • 0
1 CHEMBL76688_lig_chart_1 Cathepsin G Human
There should be some charts here, you may need to enable JavaScript!
  • kallikrein 1/Kallikrein 1 in Human [ChEMBL: CHEMBL2319] [GtoPdb: 2865] [UniProtKB: P06870]
  • This target only has 0 pki data point
  • 0
2 CHEMBL76688_lig_chart_2 Kallikrein 1 Human
There should be some charts here, you may need to enable JavaScript!
  • elastase, neutrophil expressed/Leukocyte elastase in Human [ChEMBL: CHEMBL248] [GtoPdb: 2358] [UniProtKB: P08246]
  • 7.07
3 CHEMBL76688_lig_chart_3 Leukocyte elastase Human
There should be some charts here, you may need to enable JavaScript!
  • proteinase 3/Leukocyte proteinase 3 in Human [ChEMBL: CHEMBL3900] [GtoPdb: 2401] [UniProtKB: P24158]
  • This target only has 0 pki data point
  • 0
4 CHEMBL76688_lig_chart_4 Leukocyte proteinase 3 Human
There should be some charts here, you may need to enable JavaScript!
  • elastase, neutrophil expressed in Human [GtoPdb: 2358] [UniProtKB: P08246]
  • elastase, neutrophil expressed/Neutrophil elastase in Mouse [ChEMBL: CHEMBL5156] [GtoPdb: 2358] [UniProtKB: Q3UP87]
  • This target only has 0 pki data point
  • 0
5 CHEMBL76688_lig_chart_5 elastase, neutrophil expressed HumanMouse
There should be some charts here, you may need to enable JavaScript!
  • coagulation factor II, thrombin/Thrombin in Human [ChEMBL: CHEMBL204] [GtoPdb: 2362] [UniProtKB: P00734]
  • Thrombin in Bovine [ChEMBL: CHEMBL4471] [UniProtKB: P00735]
  • This target only has 0 pki data point
  • 0
6 CHEMBL76688_lig_chart_6 Thrombin HumanBovine
There should be some charts here, you may need to enable JavaScript!
  • plasminogen activator, urokinase/Urokinase-type plasminogen activator in Human [ChEMBL: CHEMBL3286] [GtoPdb: 2393] [UniProtKB: P00749]
  • This target only has 0 pki data point
  • 0
7 CHEMBL76688_lig_chart_7 Urokinase-type plasminogen activator Human
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
cathepsin G/Cathepsin G in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4071] [GtoPdb: 2348] [UniProtKB: P08311]
ChEMBL Inhibition of human cathepsin G using Suc-Ala-Ala-Pro-Phe-p-nitroanilide as substrate incubated for 30 mins prior to substrate addition measured for 30 mins by spectrophotometry B 4 pIC50 >100000 nM IC50 J. Med. Chem. (2013) 56: 9802-9806 [PMID:24224573]
ChEMBL Inhibition of human cathepsin G using N-succinyl-Ala-Ala-Pro-Phe-p-nitroanilide as substrate measured for 180 mins by spectrophotometry B 5 pIC50 >10000 nM IC50 Bioorg. Med. Chem. (2015) 23: 1123-1134 [PMID:25650311]
kallikrein 1/Kallikrein 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2319] [GtoPdb: 2865] [UniProtKB: P06870]
ChEMBL Inhibition of human kallikrein using H-Pro-Phe-Arg-AMC acetate salt as substrate measured for 30 mins by spectrophotometry B 5.7 pIC50 >2000 nM IC50 J. Med. Chem. (2013) 56: 9802-9806 [PMID:24224573]
elastase, neutrophil expressed/Leukocyte elastase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL248] [GtoPdb: 2358] [UniProtKB: P08246]
ChEMBL Binding affinity against Elastase. B 6.7 pKi 200 nM Ki J. Med. Chem. (2000) 43: 305-341 [PMID:10669559]
ChEMBL Inhibition of human leukocyte elastase B 7.43 pKi 37 nM Ki ACS Med Chem Lett (2018) 9: 345-350 [PMID:29670698]
ChEMBL Inhibition Assay: Each of Compounds (1) to (7) was added into 50 μL buffer A (containing 20 mM Tris-HCl (pH 7.4), 0.1% NaN3 and 5 mM CaCl2) to obtain compound solutions with concentrations of 0.02, 0.2, 2, or 20 μM for each of Compounds (1) to (7), followed by m adding 50 μL of the compound solutions into wells of a 96-well plate. The buffer A and Sivelestat (under the same solvent condition and concentrations as those of Compounds (1) to (7)) with the same volume were respectively used as a control group and a positive control group. Each well of the 96-well plate was further added with 25 μL of human neutrophil elastase (Enzo, 200 nM, in buffer B containing 20 mM Tris-HCl (pH 7.4) and 0.1% NaN3) and 25 μL MeO-Suc-Ala-Ala-Pro-Val-p-nitroanilide (500 μM, prepared in the buffer B), followed by reacting in an incubator (30° C.) for 30 minutes. B 4.19 pIC50 65040 nM IC50 US-9073833-B1. Oxime-based compound, pharmaceutical composition containing the same and method for preparing the same (2015)
ChEMBL Inhibition of human neutrophil elastase assessed as proteolysis using N-(methoxysuccinyl)-Ala-Ala-Pro-Val-p-nitroanilide substrate incubated for 15 mins prior to substrate addition measured every 30 seconds B 6.87 pIC50 136 nM IC50 J. Med. Chem. (2013) 56: 1276-1290 [PMID:23350733]
ChEMBL Inhibition of human neutrophil elastase measured for 30 mins by spectrophotometry B 7.15 pIC50 70 nM IC50 Bioorg. Med. Chem. (2015) 23: 1123-1134 [PMID:25650311]
ChEMBL Release Assay: Each of Compounds (1) to (6) was dissolved in 100% DMSO so as to obtain stock to compound solutions with concentrations of 0.01, 0.03, 0.1, 0.3, 1, 3 or 10 mM) for each of Compounds (1) to (6). 7500 of the neutrophil suspension obtained in -3. Preparation of human neutrophil under the section of -Experimental materials was added with 200 uM of MeO-Suc-Ala-Ala-Pro-Val-p-nitroanilide (454454, Calbiochem Limited, dissolved in 750 ul HBSS and functioned as a substrate for human neutrophils) at a is volume ratio of 1:1 (the final volume was 1.5 ml), stirred at 37 C. for 2 minutes, followed by addition with 1.5 ul of the aforesaid compound solution and reaction at 37 C. for 2 minutes. In a control group, 100% DMSO was used to substitute the compound solution. Moreover, Sivelestat (with concentrations of 0.01, 0.03, 0.1, 0.3, 1, 3 or 10 mM in DMSO) was used to substitute the compound solution as a positive control group. B 7.3 pIC50 50 nM IC50 US-9073833-B1. Oxime-based compound, pharmaceutical composition containing the same and method for preparing the same (2015)
ChEMBL Inhibitory concentration against elastase B 7.36 pIC50 44 nM IC50 J. Med. Chem. (2000) 43: 305-341 [PMID:10669559]
ChEMBL Inhibitory concentration in vitro against Human neutrophil elastase B 7.36 pIC50 44 nM IC50 Bioorg. Med. Chem. Lett. (2002) 12: 2349-2353 [PMID:12161131]
ChEMBL Inhibition of human neutrophil elastase using N-methylsuccinyl-Ala-Ala-Pro-Val-7-amino-4-methyl-coumarin as substrate measured every 30 secs for 10 mins by fluorescence microplate reader B 7.36 pIC50 44 nM IC50 Bioorg. Med. Chem. (2011) 19: 4460-4472 [PMID:21741848]
GtoPdb - - 7.4 pIC50 44 nM IC50 Bioorg Med Chem (2011) 19: 4460-72 [PMID:21741848]
ChEMBL Inhibition of human neutrophil elastase using MeO-Suc-Ala-Ala-Pro-Val-AMC as substrate incubated for 30 mins prior to substrate addition measured for 30 mins by fluorescence assay B 8 pIC50 10 nM IC50 J. Med. Chem. (2013) 56: 9802-9806 [PMID:24224573]
proteinase 3/Leukocyte proteinase 3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3900] [GtoPdb: 2401] [UniProtKB: P24158]
ChEMBL Inhibition of human proteinase 3 using N-MeOSuc-Ala-Ala-Pro-Val-p-nitroanilide as substrate measured for 30 mins by spectrophotometry B 4 pIC50 >100000 nM IC50 J. Med. Chem. (2013) 56: 9802-9806 [PMID:24224573]
ChEMBL Inhibition of Pr3 (unknown origin) using t-butyloxycarbonyl-Ala-Ala-Nva-thiobenzyl ester as substrate measured for 180 mins by spectrophotometry B 6.47 pIC50 340 nM IC50 Bioorg. Med. Chem. (2015) 23: 1123-1134 [PMID:25650311]
elastase, neutrophil expressed in Human [GtoPdb: 2358] [UniProtKB: P08246]
GtoPdb - - 7.4 pIC50 44 nM IC50 Bioorg Med Chem (2011) 19: 4460-72 [PMID:21741848]
elastase, neutrophil expressed/Neutrophil elastase in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5156] [GtoPdb: 2358] [UniProtKB: Q3UP87]
ChEMBL Inhibition of recombinant mouse neutrophil elastase using methoxysuccinyl-Ala-Ala-Pro-Val-pnitroanilide as substrate preincubated for 15 mins before substrate addition measured after 90 mins by spectrophotometry B 6.84 pIC50 145.39 nM IC50 Bioorg. Med. Chem. (2015) 23: 1123-1134 [PMID:25650311]
coagulation factor II, thrombin/Thrombin in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL204] [GtoPdb: 2362] [UniProtKB: P00734]
ChEMBL Inhibition of human thrombin using Z-Gly-Gly-Arg-AMC.HCl as substrate measured for 30 mins by spectrophotometry B 5.7 pIC50 >2000 nM IC50 J. Med. Chem. (2013) 56: 9802-9806 [PMID:24224573]
Thrombin in Bovine (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4471] [UniProtKB: P00735]
ChEMBL Inhibition of bovine plasma thrombin using Benzoyl-Phe-Val-Arg-7-amido-4-methylcoumarin hydrochloride by spectrophotometry B 5 pIC50 >10000 nM IC50 Bioorg. Med. Chem. (2015) 23: 1123-1134 [PMID:25650311]
plasminogen activator, urokinase/Urokinase-type plasminogen activator in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3286] [GtoPdb: 2393] [UniProtKB: P00749]
ChEMBL Inhibition of human urokinase using Z-Gly-Gly-Arg-AMC.HCl as substrate measured for 30 mins by spectrophotometry B 5.7 pIC50 >2000 nM IC50 J. Med. Chem. (2013) 56: 9802-9806 [PMID:24224573]

ChEMBL data shown on this page come from version 28:

Gaulton A, Hersey A, Nowotka M, Bento AP, Chambers J, Mendez D, Mutowo P, Atkinson F, Bellis LJ, Cibrián-Uhalte E, Davies M, Dedman N, Karlsson A, Magariños MP, Overington JP, Papadatos G, Smit I, Leach AR. (2017) 'The ChEMBL database in 2017.' Nucleic Acids Res., 45(D1). DOI: 10.1093/nar/gkw1074. [PMCID:5210557]